(Q40477675)

20 September 2017

Glycine-amide is an active metabolite of the antiretroviral tripeptide glycyl-prolyl-glycine-amide (English)

1 reference

20 September 2017

anti-retroviral agent

0 references

5

Jan Balzarini

1 reference

20 September 2017

Elin Andersson

1

1 reference

20 September 2017

Peter Horal

2

1 reference

20 September 2017

Alenka Jejcic

3

1 reference

20 September 2017

Stefan Höglund

4

1 reference

20 September 2017

Anders Vahlne

6

1 reference

20 September 2017

Bo Svennerholm

7

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

Antimicrobial Agents and Chemotherapy

20 September 2017

1 reference

20 September 2017

49

1 reference

20 September 2017

1

1 reference

20 September 2017

40-44

1 reference

Worldwide transmission of drug-resistant HIV

20 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

Tripeptide interference with human immunodeficiency virus type 1 morphogenesis

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

The nontoxic tripeptide glycyl-prolyl-glycine amide inhibits the replication of human immunodeficiency virus type 1.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

Protein metabolism and the gut.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

CD26, let it cut or cut it down.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

Obligatory involvement of CD26/dipeptidyl peptidase IV in the activation of the antiretroviral tripeptide glycylprolylglycinamide (GPG-NH(2)).

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

No cross-resistance or selection of HIV-1 resistant mutants in vitro to the antiretroviral tripeptide glycyl-prolyl-glycine-amide

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

The safety, plasma pharmacokinetics, and antiviral activity of subcutaneous enfuvirtide (T-20), a peptide inhibitor of gp41-mediated virus fusion, in HIV-infected adults.

20 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=538866

European guidelines for the clinical management and treatment of HIV-infected adults in Europe

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/15616273

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1128/AAC.49.1.40-44.2005

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5yhfydfhuzclzjbgmmd67zc5cq

30 July 2022

release_5yhfydfhuzclzjbgmmd67zc5cq

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5yhfydfhuzclzjbgmmd67zc5cq

30 July 2022

https://api.fatcat.wiki/v0/release/5yhfydfhuzclzjbgmmd67zc5cq

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/5yhfydfhuzclzjbgmmd67zc5cq

PubMed publication ID

1 reference

30 July 2022